|256.33||+0.8000||+0.31%||Vol 1.17M||1Y Perf 119.85%|
|Sep 24th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||274.00||Analyst Rating||Strong Buy 1.40|
|Potential %||6.89||Finscreener Ranking||+ 36.97|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||☆ 30.69|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★+ 40.64|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||☆ 21.32|
|Price Range Ratio 52W %||94.88||Earnings Rating||Strong Buy|
|Market Cap||82.06B||Earnings Date||25th Oct 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|10 Years||1 543.58%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||25th Oct 2021|
|Estimated EPS Next Report||3.81|
|EPS Growth Next 5 Years %||11.10|
|Avg. Weekly Volume||1.28M|
|Avg. Monthly Volume||1.50M|
|Avg. Quarterly Volume||1.37M|
HCA Healthcare Inc. (NYSE: HCA) stock closed at 256.33 per share at the end of the most recent trading day (a 0.31% change compared to the prior day closing price) with a volume of 1.18M shares and market capitalization of 82.06B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 275000 people. HCA Healthcare Inc. CEO is Samuel N. Hazen.
The one-year performance of HCA Healthcare Inc. stock is 119.85%, while year-to-date (YTD) performance is 55.86%. HCA stock has a five-year performance of 236.74%. Its 52-week range is between 115.74 and 263.92, which gives HCA stock a 52-week price range ratio of 94.88%
HCA Healthcare Inc. currently has a PE ratio of 17.70, a price-to-book (PB) ratio of 291.34, a price-to-sale (PS) ratio of 1.46, a price to cashflow ratio of 26.20, a PEG ratio of 2.32, a ROA of 9.98%, a ROC of 5.19% and a ROE of -400.94%. The company’s profit margin is 10.27%, its EBITDA margin is 20.40%, and its revenue ttm is $56.02 Billion , which makes it $174.97 revenue per share.
Of the last four earnings reports from HCA Healthcare Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $3.81 for the next earnings report. HCA Healthcare Inc.’s next earnings report date is 25th Oct 2021.
The consensus rating of Wall Street analysts for HCA Healthcare Inc. is Strong Buy (1.4), with a target price of $274, which is +6.89% compared to the current price. The earnings rating for HCA Healthcare Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
HCA Healthcare Inc. has a dividend yield of 0.75% with a dividend per share of $1.92 and a payout ratio of 3.00%.
HCA Healthcare Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 15.29, ATR14 : 4.98, CCI20 : 43.45, Chaikin Money Flow : -0.27, MACD : 2.77, Money Flow Index : 60.75, ROC : 0.75, RSI : 55.78, STOCH (14,3) : 51.10, STOCH RSI : 0.08, UO : 39.40, Williams %R : -48.90), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of HCA Healthcare Inc. in the last 12-months were: A. Bruce Moore (Option Excercise at a value of $2 541 750), A. Bruce Moore (Sold 22 000 shares of value $4 263 142 ), Charles J. Hall (Option Excercise at a value of $1 489 335), Charles J. Hall (Sold 30 536 shares of value $5 364 421 ), Christopher F. Wyatt (Option Excercise at a value of $1 437 638), Christopher F. Wyatt (Sold 7 804 shares of value $1 505 796 ), Deborah M. Reiner (Option Excercise at a value of $756 847), Deborah M. Reiner (Sold 9 776 shares of value $1 681 805 ), J. William B. Morrow (Sold 9 218 shares of value $1 396 132 ), Jane D. Englebright (Option Excercise at a value of $537 581), Jane D. Englebright (Sold 16 768 shares of value $3 394 847 ), Jennifer Berres (Option Excercise at a value of $813 110), Jennifer Berres (Sold 10 164 shares of value $1 661 384 ), Jon M. Foster (Option Excercise at a value of $1 726 920), Jon M. Foster (Sold 17 107 shares of value $3 172 869 ), Jonathan B. Perlin (Option Excercise at a value of $16 802 663), Jonathan B. Perlin (Sold 163 228 shares of value $33 495 722 ), Kathleen M. Whalen (Option Excercise at a value of $67 158), Kathleen M. Whalen (Sold 1 166 shares of value $268 343 ), Kathryn A. Torres (Option Excercise at a value of $2 012 459), Kathryn A. Torres (Sold 8 483 shares of value $1 631 705 ), Martin P. Paslick (Option Excercise at a value of $1 464 284), Martin P. Paslick (Sold 10 658 shares of value $1 554 265 ), Michael S. Cuffe (Option Excercise at a value of $3 305 037), Michael S. Cuffe (Sold 42 456 shares of value $8 105 007 ), P. Martin Paslick (Option Excercise at a value of $3 962 950), P. Martin Paslick (Sold 19 227 shares of value $4 078 601 ), Robert A. Waterman (Option Excercise at a value of $9 237 352), Robert A. Waterman (Sold 218 042 shares of value $40 972 542 ), Samuel N. Hazen (Option Excercise at a value of $15 135 876), Samuel N. Hazen (Sold 121 875 shares of value $16 527 839 ), Sandra L. Morgan (Sold 5 030 shares of value $642 564 ), Wayne Joseph Riley (Sold 4 950 shares of value $876 464 ), William B. Rutherford (Option Excercise at a value of $2 007 696), William B. Rutherford (Sold 36 250 shares of value $5 050 676 ), William J Morrow (Option Excercise at a value of $971 877), William J Morrow (Sold 13 058 shares of value $1 911 624 )
Tue, 21 Sep 2021 13:50 GMT HCA Healthcare Inks Deal to Buy Operations of Five Utah Hospitals- TipRanks. All rights reserved.
Fri, 27 Aug 2021 09:05 GMT Analysts Top Healthcare Picks: HCA Healthcare (HCA)- TipRanks. All rights reserved.
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.